DIRS.INFO The most relevant business & tech news

Down to $164.99, this Prime Day price matches the record low we saw for Black Friday. $10.14 from Amazon Originally $25.00 Save 59%Prime Day deals: StyleWe've got you covered for head-to-toe deals across the fashion world today. This Prime Day deal is the best price we've ever seen, and it's only available by invite for Prime members during Amazon Prime Day. $12.99 from Amazon Originally $23.99 Save 46%More Prime Day dealsDeal icon An icon in the shape of a lightning bolt. You'll also get a bonus of $10 with this Prime Day deal when you use the code "HAPPY" and spend $50.

Persons: we've, snagging, We're, you've, we'd, We've, they're, it's, Amazon’s, eero, You'll, Apple, Bose, AirPods, Price, Price Roku, Dolby, Max, Price Casper, Casper, Coop, it’s, It's, Rich, wicks, Price Bowflex, Garmin Venu, Venu, you’ve, Riley C.E.O, Sunday Riley, It’s, Murad Retinol, Kit Burt's, Kit, Kenneth Cole, Steven Madden, Martens, Vines, Herschel, Price Calvin Klein, Calvin Klein racerback, Now's, JW Pei, Price Apple, Price Arlo, we’ve, Bento, bento, you'll, LaCroix, seltzer, Foodi, Fryer, fryer, Hoover, Decker, Dyson, Bissell, Zelda, Price Hori, Con, Ed, Collar, Gray, Inaba, Brown Rice, Robin Organizations: Apple, Amazon, Prime, Black, Alexa, Amazon's, Echo Studio, Music, Amazon Deal, Price Apple, Samsung, LG, Walmart, Casper, Health, Bands, Price Garmin, Garmin, OSHA, Optimum, Theragun's, Amazon Prime, Sunday, Panasonic, frizz, Adidas, Chelsea, Herschel Supply, Deal, Navy, Columbia, Energy, Steam, IRIS, GE, OmieGo, ICE, Quart, ICM, Deal LG, Fire, Price LG, PlayStation, Google, Price NVIDIA, Computers, Gaming, Nintendo, MacBook Air, Asus, Mobile, Lenovo, Intel, AMD, Monitor, Seagate, Dell, Monitor Samsung, Gray, Super Nintendo Entertainment, ASUS, Buffalo, Pets, Deal Samsung Galaxy, Galaxy, Fujifilm, Marvel, Deal Indiana Jones, Indiana Jones, — Raiders Locations: Siena, Birch, Sol, Colombia, Cha Kyusu, sharpener, Whynter, it's, It's, Kingdom

Prime Day 2023 ends tonight and we're still working hard to round up all the best deals of day 2. Down to $164.99, this Prime Day price matches the record low we saw for Black Friday. On select sizes and colors, you can get up to 60% off, the lowest Prime Day price to date. Even with a newer C3 model out this year, this remains a better value, especially at this current Prime Day deal price. This Prime Day deal is the best price we've ever seen, and it's only available by invite for Prime members during Amazon Prime Day.

Persons: we're, we've, snagging, We're, I've, Sarah Saril, you've, we'd, We've, they're, it's, Amazon’s, eero, You'll, Apple, Bose, AirPods, Price, Price Roku, Dolby, Max, Price Casper, Casper, Coop, it’s, It's, Rich, wicks, Price Bowflex, Garmin Venu, Venu, you’ve, Luna, Riley C.E.O, Sunday Riley, It’s, Murad Retinol, Kit Burt's, Kit, They're, Snuggies, Elaine Benes, Kenneth Cole, Steven Madden, Martens, Ray Bans, Vines, Price Calvin Klein, Calvin Klein racerback, Grey Heather, Now's, JW Pei, Price Honeywell, Price Apple, Price Arlo, we’ve, fryer, Bento, bento, you'll, LaCroix, seltzer, Foodi, Fryer, Pro Air Fryer, Price Dyson, Dyson, Hoover, Decker, Bissell, Price Dell, Price LG, Ed, Swift, Zelda, Price Hori, Con Organizations: Tech, Apple, Amazon, Prime, Black, Alexa, Amazon's, Echo Studio, Music, Price Apple, Price Sony WH, Sony, Samsung, LG, Walmart, Casper, Health, Bands, Price Garmin, Garmin, OSHA, Optimum, Theragun's, Amazon Prime, Sunday, Panasonic, frizz, Amazon Deal, GAP, Adidas, Chelsea, Deal, Navy, Columbia, Honeywell, Energy, Steam, IRIS, GE, Oster Digital, Fryer, Oster, OmieGo, ICE, Pro Air, ICM, Deal LG, Fire, Price LG, PlayStation, Google, Price NVIDIA, HP, Price Samsung, MacBook Air, Asus, Mobile, Lenovo, Intel, AMD, Monitor, Seagate, Dell, Monitor Samsung, ASUS, Gaming, EA Star Wars, Star, Nintendo, Gray, Super Nintendo Entertainment Locations: Siena, Birch, Sol, Colombia, Cha Kyusu, sharpener, Whynter, it's, It's

To help you score all the best Prime Day discounts, we're rounding up all of the best Prime Day PC gaming deals. Top 7 Prime Day PC gaming dealsThe best Prime Day gaming laptop dealsGaming laptops are down to low prices for Prime Day. $1,999.99 from Amazon Originally $3,199.99 Save 38%The best Prime Day gaming desktop dealsYou can snag great gaming desktops with powerful hardware at a discount on Prime Day. $1,259.99 from Amazon Originally $1,399.99 Save 10%The best Prime Day gaming monitor dealsAmazon's Prime Day sale includes big deals on gaming monitors from HP, LG, and more. $169.99 from Amazon Originally $249.99 Save 32%The best Prime Day gaming headset dealsGaming headsets are seeing great Prime Day discounts right now.

Persons: Marti Bug, That's, DisobeyArt, it'll, William Antonelli, Price Razer, Price Organizations: Amazon, ASUS, Intel, Razer, Getty, HP, LG, DC, Nvidia, AMD, Prime, Asus, Logitech, PlayStation, Amazon's, Price Logitech, Lightspeed, Bluetooth, Samsung, titans

☆ Nvidia deepens bets on AI in drug discovery with Recursion investment
▼ + stars: | 2023-07-12 | by ( ) www.reuters.com time to read: +2 min

July 12 (Reuters) - Chip designer Nvidia (NVDA.O) will invest $50 million to speed up training of Recursion's (RXRX.O) artificial intelligence models for drug discovery, the companies said on Wednesday, sending the biotech firm's shares surging about 62%. Recursion, whose advisers include AI pioneer Yoshua Bengio, will use its biological and chemical datasets exceeding 23,000 terabytes to train AI models on Nvidia's cloud platform. Nvidia, seen as a big winner of the boom in artificial intelligence, could then license those models to biotech firms through BioNeMo, a generative AI cloud service for drug discovery that it rolled out earlier this year. The investment comes as Recursion strengthened its AI focus in May by snapping up two companies in the AI-driven drug discovery space for $87.5 million. The Salt Lake City, Utah-based company's current partners include Bayer (BAYGn.DE) and Roche (ROG.S).

Persons: Nvidia, Roche, Mubadala, Baillie Gifford, Chavi Mehta, Stephen Nellis, Mariam Sunny, Shilpi Majumdar, Sriraj Organizations: Nvidia, Bayer, Baillie Gifford & Co, Thomson Locations: BioNeMo, Salt Lake City , Utah, Abu, Bengaluru, San Francisco

Amazon Prime Day is here, and that means exclusive Prime Day discounts on thousands of products, including gaming PCs, headsets, and monitors. To help you score all the best Prime Day discounts, we're rounding up all of the best Prime Day PC gaming deals. Top 4 Prime Day PC gaming dealsThe best Prime Day gaming laptop dealsGaming laptops are down to low prices for Prime Day. $1,259.99 from Amazon Originally $1,399.99 Save 10%The best Prime Day gaming monitor dealsAmazon's Prime Day sale includes big deals on gaming monitors from HP, LG, and more. $169.99 from Amazon Originally $249.99 Save 32%The best Prime Day gaming headset dealsGaming headsets are seeing great Prime Day discounts right now.

Amazon Prime Day is here, and we're rounding up all the best Prime Day deals, including discounts on monitors for gaming and home offices. Popular brands like Samsung, LG, and Dell have discounted monitors by 20% or more, and we've sorted through the selection to find the best Prime Day monitor deals. Top 3 monitor dealsBest Prime Day monitor deals LG's UltraFine 4K monitor is being discounted right now for Prime Day. For more details on how to find a great monitor, check out our guides to the best computer monitor and best gaming monitor. You can also check out our best gaming PC and best gaming laptop guides for more computer hardware recommendations.

Persons: We've, it's, Price Organizations: Amazon, Samsung, LG, Dell, Asus, Prime, SAMSUNG, Deal LG, Netflix, YouTube, ASUS, Monitor Samsung, Computer

Below are the 13 best Amazon Prime Day deals that are still active. The items that don't sell out will be on sale until the end of Prime Day, 11:59 p.m. Pacific on July 12. Scroll down for the best deals, and check out our other Prime Day deals articles for more recommendations. Top 13 Amazon Prime Day deals still availableDeal icon An icon in the shape of a lightning bolt. Each year is different, but usually the Prime Day deals that sell fastest are discounts of 50% or more.

Persons: it's, Price, AirPods, It's, It’s, it’s, they're, BISSELL, Casper, Fryer, fryer Organizations: Amazon, Garmin, Black, Asus, Mobile, Bissell, Casper, Crisp Digital Locations: Pacific, it's

Limited-Time Deal Amazon Music Unlimited (Prime Member Plan) Amazon Music Unlimited lets you stream more than 90 million songs ad-free and millions of podcasts. $16.99 from Amazon Originally $29.99 Save 43%Prime Day deals: AudioDeal icon An icon in the shape of a lightning bolt. Deal Amazon Echo Buds (2023) If you need a new pair of wireless earbuds with decent sound, try the newest Echo Buds. $279.99 from Amazon Originally $499.99 Save 44%Prime Day deals: BeautyDeal icon An icon in the shape of a lightning bolt. $145.00 from Amazon Originally $210.00 Save 31%More Prime Day dealsDeal icon An icon in the shape of a lightning bolt.

Persons: We're, we've, Amazon’s, eero, AirPods, Price, it's, Price Roku, Dolby, you've, Max, Price Casper, Casper, It's, Coop, Rich, wicks, Price Bowflex, Garmin Venu, Venu, you’ve, Riley C.E.O, Sunday Riley, It’s, it’s, Murad Retinol, Kit Burt's, Kit, you'll, LaCroix, seltzer, Foodi, Fryer, fryer, they're, Price Arlo, Dyson, Collar, You'll, Gray Organizations: Amazon, Alexa, Amazon's, Echo Studio, Music, Prime, Price Apple, Samsung, Apple, LG, Amazon Prime, Walmart, Casper, Health, Fitness, Price Garmin, Garmin, Optimum, Theragun's, Sunbeam, Sunday, Panasonic, Amazon Deal, Energy, AA, Black, Steam, Quart, Deal LG, Fire, Price LG, PlayStation, Google, MacBook Air, Asus, Mobile, Lenovo, ASUS, Monitor, Seagate, Deal Samsung Galaxy, Galaxy, Fujifilm, TSA Locations: Siena, Birch, Sol, it's, sharpener

BEIJING, July 5 (Reuters) - China's Commerce Minister told foreign pharmaceuticals firms they can expect "more development opportunities" during a roundtable on Wednesday, his ministry said, as drugmakers bemoan government procurement policies pricing them out of the market. Foreign pharmaceuticals firms have struggled to cement any inroads they have made into the world's second-largest economy, with the government maintaining a drug procurement programme that forces them to slash their prices and refusing to approve the use of any foreign COVID-19 vaccines during the pandemic. But as China pursues home-grown modernisation it will also open up "more development opportunities for foreign-funded enterprises, including the pharmaceutical industry," Wang told the meeting. Wang told the meeting on Wednesday that his ministry will expand the channels of communication for responding to and solving concerns, with the meeting resulting in 25 specific suggestions to be taken forward. Reporting by Joe Cash; Additional reporting by Kevin Yao;Editing by Elaine HardcastleOur Standards: The Thomson Reuters Trust Principles.

Persons: Roche, Takeda, Wang Wentao, Wang, Li Qiang, Li, drugmakers, Joe Cash, Kevin Yao, Elaine Hardcastle Organizations: China's Commerce, AstraZeneca, Bayer, Merck, Novo Nordisk, Pfizer, Sanofi, Moderna, Wednesday, Economic, Thomson Locations: BEIJING, China, Tianjin

☆ US FDA approves BioMarin's gene therapy for hemophilia A
▼ + stars: | 2023-06-29 | by ( Nathan Gomes | ) www.reuters.com time to read: +3 min

It priced the one-time therapy, Roctavian, at $2.9 million. BioMarin said most study participants continued to respond to the gene therapy through year three and beyond, and it would continue to monitor them for 15 years. BioMarin's therapy will compete for market share with Roche's (ROG.S) Hemlibra, an antibody drug which mimics the function of the blood clotting protein missing in hemophilia A patients. In April, BioMarin cut its annual sales forecast range for Roctavian to $50 million to $100 million, from $100 million to $200 million. There are about 16,000 patients in the United States with hemophilia A in which they are missing the factor VIII clotting protein.

Persons: BioMarin, Joel Beatty, Robert W Baird, Roctavian, Beatty, Khushi Mandowara, Bhanvi Satija, Nathan Gomes, Akash Sriram, Deena Beasley, Krishna Chandra Eluri, Maju Samuel, David Gregorio Our Organizations: U.S . Food, Drug Administration, European Union, Los, Thomson Locations: U.S, California, Novato , California, hemophilia, United States, Bengaluru, Los Angeles

The pan-European STOXX 600 index (.STOXX) closed 0.7% higher, tracking overnight gains in Wall Street. Shares of Sage Group Plc (SGE.L) gained 5.1% to a 23-year high after J.P. Morgan upgraded its rating on the stock to "overweight" from "neutral". Shares of chip equipment maker ASML Holding (ASML.AS) rose 2.3% while Nordic Semiconductor (NOD.OL) jumped 6.4%, making technology (.SX8P) among the top European sectoral gainers. Semiconductor shares were in focus after a report stated the U.S. was considering new restrictions on exports of artificial intelligence chips to China. Also boosting the STOXX 600, Roche Holding (ROG.S) gained 1.5% after the U.S. health regulator declined to approve Regeneron's (REGN.O) Eylea drug.

Persons: Christine Lagarde, Jerome Powell, what's, Danni Hewson, AJ Bell, Morgan, Hewson, Roche, Morgan Stanley, Christian Klein, Matteo Allievi, Subhranshu Sahu, Sherry Jacob, Phillips, Alex Richardson Organizations: Sage Group, UBS, CS, . Federal, ASML, Nordic Semiconductor, Semiconductor, Carrefour, Credit Suisse, SAP, Thomson Locations: Wall, U.S, China, Swiss, Gdansk, Amruta, Bangalore

☆ European shares rise as US data soothes economic slowdown fears
▼ + stars: | 2023-06-28 | by ( ) www.reuters.com time to read: +1 min

June 28 (Reuters) - European shares climbed on Wednesday after robust U.S. data soothed concerns about a steep economic slowdown, while investors awaited commentary from central bankers at a forum later in the day for further policy direction. The pan-European STOXX 600 index (.STOXX) was up 0.5% by 0810 GMT, tracking Wall Street's gains overnight after data showed a rise in new orders for key U.S.-manufactured capital goods and heightened consumer confidence in June. Investors are keenly watching a panel discussion of central bankers in Sintra, including European Central Bank President Christine Lagarde, Federal Reserve Chair Jerome Powell and Bank of Japan Governor Kazuo Ueda. French supermarket chain Carrefour (CARR.PA) gained 3.1% after Morgan Stanley initiated coverage with an "overweight" rating. Reporting by Matteo Allievi in Gdansk and Amruta Khandekar in Bangalore; Editing by Subhranshu SahuOur Standards: The Thomson Reuters Trust Principles.

Persons: Christine Lagarde, Jerome Powell, Kazuo Ueda, Morgan Stanley, Matteo Allievi, Subhranshu Sahu Organizations: Roche, Investors, European Central Bank, Bank of Japan, Carrefour, Thomson Locations: Sintra, Gdansk, Amruta, Bangalore

☆ US FDA declines to approve Regeneron's higher-dose Eylea, shares tumble
▼ + stars: | 2023-06-27 | by ( ) www.reuters.com time to read: +2 min

The Food and Drug Administration cited an ongoing review of inspection findings at a third-party filler of the higher dose for the decision. Eylea, which recorded $9.65 billion in global sales last year, has been hit since Roche's (ROG.S) rival treatment Vabysmo was approved last year for wet AMD. Two late-stage trials had shown Eylea was as effective as the lower dose version when given at 8 milligrams at longer intervals without any additional safety issues. The two trials included treatment of patients with wet AMD and diabetic macular edema (DME). An estimated 1.1 million people in the U.S. have wet AMD, while 1.2 million are estimated to have DME, according to Regeneron.

Persons: Vabysmo, Regeneron, Eylea, Raghav Mahobe, Krishna Chandra Eluri, Maju Samuel, Sriraj Organizations: Regeneron Pharmaceuticals, Drug Administration, FDA, AMD, biosimilars, Thomson Locations: U.S, Bengaluru

☆ Novartis buys Chinook for $3.5 bln in race to treat rare kidney disease
▼ + stars: | 2023-06-12 | by ( Ludwig Burger | ) www.reuters.com time to read: +3 min

June 12 (Reuters) - Novartis (NOVN.S) said it has agreed to acquire U.S. biotech firm Chinook Therapeutics (KDNY.O) for up to $3.5 billion to boost its late-stage drug development line-up, raising the stakes in the race for a rare kidney disease treatment. The other drug hopeful is iptacopan, which is being trialled against a number of rare genetic disorders, including IgAN and another kidney disease. IgAN is a progressive autoimmune disease that mostly affects young adults and which can lead to kidney failure that requires dialysis or organ transplantation. IgAN is the most common cause of kidney failure in Caucasian young adults, Novartis added. Additional reporting by Miranda Murray; Editing by Kim Coghill, Sonali Paul and Alexander SmithOur Standards: The Thomson Reuters Trust Principles.

Persons: Novartis, Vas Narasimhan, Narasimham, atrasentan, Narasimhan, Kisqali, Roche, Vera, Muddy Waters, Miranda Murray, Kim Coghill, Sonali Paul, Alexander Smith Organizations: Novartis, Chinook Therapeutics, Vera Therapeutics, Sandoz, Chinook, Thomson Locations: Seattle, United States

☆ These 9 global stocks have raised dividends for the last 30 years
▼ + stars: | 2023-06-07 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

Nine global stocks have raised dividends every year for the past three decades, according to CNBC Pro analysis. Of about 92,000 global stocks screened by CNBC Pro, the following nine consistently rewarded their shareholders. Novartis' stock has been on an upward trend recently – rising 8.9% year to date – after moving sideways for more than six months. Novartis' dividend yield is currently 3.5%. NOVNEE-CH 1Y line Roche Like its peer Novartis, Roche , the pharmaceuticals and diagnostics company headquartered in Basel, Switzerland, offers a 3.3% dividend yield.

Persons: Maurice Choy, . Choy, Eric Le Berrigaud, Roche, Luisa Hector, James Halstead Organizations: CNBC, CNBC Pro, Fortis Canadian, Fortis, RBC Capital, Novartis, Roche, Pharma, Sage Group, Kerry Locations: Novartis Swiss, Basel, Switzerland, ROG, Spirax, Saco

☆ Indivior opioid settlement makes purer M&A case
▼ + stars: | 2023-06-05 | by ( ) www.reuters.com time to read: +2 min

LONDON, June 5 (Reuters Breakingviews) - Indivior (INDV.L) is one step closer to becoming a takeover target. Litigation risks have weighed down Indivior in the years following the company’s spinoff from Reckitt Benckiser (RKT.L) in 2014. The group still has lawsuits to settle over the same charges with insurers and patients. With its litigation risks easing, Indivior could soon lure larger cash rich pharmaceutical companies keen to access a market that is sadly showing no signs of decline. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

Persons: Reckitt, Roche, Indivior, Aimee Donnellan, Neil Unmack, Streisand Neto Organizations: Reuters, Suboxone, AstraZeneca, U.S . Centers for Disease Control, Twitter, Toyota, Thomson Locations: U.S

☆ Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
▼ + stars: | 2023-06-05 | by ( Julie Steenhuysen | ) www.reuters.com time to read: +5 min

The hope is for "a completely new treatment paradigm in cancer that will be better tolerated and unique to individual patients' tumors," said Dr. Jane Healy, an executive overseeing in early cancer treatment development at Merck. The Merck/Moderna collaboration is one of several combining powerful drugs that unleash the immune system to target cancers with mRNA vaccine technology. Aiming at these unique proteins allows the immune system to kill cancer cells while leaving healthy tissue unscathed. With standard treatment, 90% of pancreatic cancer patients die within five years of diagnosis. The approach first primes the immune system with an older technology called a chimpanzee adenovirus vaccine that targets patients' tumors.

Persons: Andrew Kelly, Keytruda, Jane Healy, Germany's BioNTech, Vinod Balachandran, we've, we're, Andrew Allen, Healy, Julie Steenhuysen, Caroline Humer, Bill Berkrot Organizations: Merck & Co, REUTERS, CHICAGO, Moderna Inc, American Society of Clinical Oncology, Merck, Moderna, Memorial Sloan Kettering Cancer Center, Thomson Locations: Kenilworth , New Jersey, U.S, Chicago, New York, Nature

One of their most interesting products is the ROG Flow Z13. But last month, Asus sent Insider a limited edition version of the Flow Z13, called the Asus ROG Flow Z13-ACRNM RMT02. ROG Flow Z13-ACRNM RMT02 is a mouthful of a name, which is just one reason why I've taken to just calling it the "Asus Alien." To put it simply: The Z13-ACRNM looks like it came from an alien civilization. Check out below what this one-off laptop looks like.

In 2017, with Mr. Connors’ help, Mr. Maichle started his own company, Precision Compliance Consulting. ‘Boss Man’Mr. Connors, Mr. Lewis and Mr. Maichle were all active in college conservative politics in Wisconsin about 15 years ago, when Mr. Connors was the leader of campus Republicans at Marquette University. Of that, about $102,000 went to Campaign Now, the firm started by Mr. Connors, and another $112,000 to companies where Mr. Connors, Mr. Maichle or Mr. Lewis was either the owner or a partner, tax records show. Most of the money — more than $4.4 million — went to fund-raising companies via tens of thousands of small payments. Most of the money — more than $4.4 million — went to fund-raising companies via tens of thousands of small payments.

The Asus ROG Ally is a brand-new handheld gaming system that's set to hit Best Buy on June 13. On top of all that, the ROG Ally boasts more powerful hardware than even the Steam Deck. Asus plans on releasing two different versions: One with an AMD Z1 Extreme CPU that costs $700, and another with a weaker AMD Z1 chip for $600. Asus ROG Ally Gaming Handheld (Z1 Extreme) The Asus ROG Ally is a handheld gaming PC, running Windows 11. The ROG Ally is a mediocre way to use Windows 11Asus has built the ROG Ally to run Windows 11.

☆ BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
▼ + stars: | 2023-05-10 | by ( ) www.reuters.com time to read: +2 min

FRANKFURT, May 10 (Reuters) - Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech (22UAy.DE) potentially bodes well for the future of fighting an extremely aggressive form of cancer after the regimen was shown to trigger a promising immune reaction in some pancreatic cancer patients. Pancreatic cancer is among the most deadly forms of cancer because it typically grows undetected until an effective treatment is too late. The trial focused on pancreatic ductal adenocarcinoma (PDAC), which accounts for more than 90% of pancreatic cancer cases. Nature covers a wide range of topics in science and technology beyond medicine. Among the eight trial participants with a detectable immune response, there was no evidence of cancer recurrence 18 months after surgery, while the median time to recurrence was 13.4 months among the non-responders.

☆ Regeneron's Eylea drug misses sales estimates as competition heats up
▼ + stars: | 2023-05-04 | by ( ) www.reuters.com time to read: +1 min

The drug recorded sales of $2.28 billion in the quarter, missing expectations of $2.43 billion, according to an average of six analysts' estimates polled by Refinitiv. The company has also been leaning on its anti-inflammatory drug Dupixent - a treatment currently approved for five indications including asthma and atopic dermatitis, or eczema. Quarterly sales of Dupixent, recorded by Regeneron's partner Sanofi (SASY.PA), rose about 37% to $2.49 billion, above expectations of $2.38 billion. Regeneron's total revenue of $3.16 billion beat estimates of $3 billion. Excluding items, the company reported a profit of $10.09 per share, above estimates of $9.56.

☆ Roche Q1 sales decline tempered by swift uptake of new eye drug
▼ + stars: | 2023-04-26 | by ( Ludwig Burger | ) www.reuters.com time to read: +2 min

[1/2] The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. Quarterly group revenue fell to 15.3 billion Swiss francs ($17.2 billion), the company reported on Wednesday, beating market expectations of 14.8 billion francs. The company, which does not report earnings for its first and third quarter, reiterated that pandemic-related sales - mainly lab testing, antibody treatment Ronapreve and repurposed arthritis drug Actemra - would drop by 5 billion francs this year. "We are very happy with the very rapid and significant uptake in the different markets around the world," he said on a media call. Sales and core earnings per share were still expected to decrease at a "low single-digit" percentage in 2023, the pharmaceuticals and diagnostics company added.

☆ Roche Q1 sales down 7% as COVID-related business wanes
▼ + stars: | 2023-04-26 | by ( ) www.reuters.com time to read: 1 min

April 26 (Reuters) - Swiss drugmaker Roche (ROG.S) said first-quarter sales dropped 7% on falling demand for its COVID-19 therapies and diagnostics kits. Quarterly group revenue fell to 15.3 billion Swiss francs ($17.2 billion), the company reported on Wednesday, beating market expectations of 14.8 billion francs. The company does not report earnings for its first and third quarter. Reporting by Ludwig Burger, editing by Kirsti KnolleOur Standards: The Thomson Reuters Trust Principles.

REUTERS/Tom KaeckenhoffLEVERKUSEN, Germany, April 5 (Reuters) - Incoming Bayer (BAYGn.DE) chief executive Bill Anderson says he is keeping an open mind on whether to break up the company into smaller pieces, as some fidgety investors want. "That's why I said I am going to have an open mind," he said. On the stock market Bayer, once the most valuable company on Germany's DAX blue-chip index, is now worth only about the same as it paid for Monsanto. At Bayer, he said he did not have his own desk and made use of the company's meeting rooms as needed. Professing a love of American football, hiking and snowboarding, he was also effusive about Bayer as a company and its heritage of medicines such as Aspirin.

Search resuls for: "ROG"

25 mentions found